Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7586)
All Articles published online
|
Publishing Process of This Article
|
Feb 26, 2017 (publication date) through Apr 28, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Anantha Narayanan M, Reddy YNV, Baskaran J, Deshmukh A, Benditt DG, Raveendran G. Ivabradine in the treatment of systolic heart failure - A systematic review and meta-analysis. World J Cardiol 2017; 9(2): 182-190 [PMID: 28289533 DOI: 10.4330/wjc.v9.i2.182] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v9/i2/182.htm |
| Number | Citing Articles |
| 1 |
David C. Booth, Navin Rajagopalan. Cardiovascular Hemodynamics. Contemporary Cardiology 2019; : 105 doi: 10.1007/978-3-030-19131-3_8
|
| 2 |
Zeba M. Khan, Jean Baptiste Briere, Elzbieta Olewinska, Fatma Khrouf, Mateusz Nikodem. Ivabradine in patients with heart failure: a systematic literature review. Journal of Market Access & Health Policy 2023; 11(1) doi: 10.1080/20016689.2023.2262073
|
| 3 |
Amy Walters, Germaine Ferreira. The Therapist's Role in the Medical and Pharmacological Management of Heart Failure. Topics in Geriatric Rehabilitation 2019; 35(1): 2 doi: 10.1097/TGR.0000000000000213
|
| 4 |
Boniface Malangu, Gregg M. Lanier, William H. Frishman. Nonpharmacologic Treatment for Heart Failure. Cardiology in Review 2021; 29(1): 48 doi: 10.1097/CRD.0000000000000307
|
| 5 |
Mohamed Toufic El Hussein, Samir Negash. Cluster Scheme Approach to Foundational Heart Failure With Reduced Ejection Fraction Therapy. The Journal for Nurse Practitioners 2022; 18(6): 628 doi: 10.1016/j.nurpra.2022.02.009
|
| 6 |
Edimar Alcides Bocchi, Vera Maria Cury Salemi. Ivabradine for treatment of heart failure. Expert Opinion on Drug Safety 2019; 18(5): 393 doi: 10.1080/14740338.2019.1612873
|
| 7 |
M. Maagaard, E. E. Nielsen, C. Gluud, J. C. Jakobsen. Ivabradine for coronary artery disease and/or heart failure—a protocol for a systematic review of randomised clinical trials with meta-analysis and Trial Sequential Analysis. Systematic Reviews 2019; 8(1) doi: 10.1186/s13643-019-0957-0
|
| 8 |
Sasmita Bryan Richard, Bi Huang, Gang Liu, Yuan Yang, Suxin Luo. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta‐analysis of randomized controlled trials. Clinical Cardiology 2021; 44(4): 463 doi: 10.1002/clc.23581
|
| 9 |
Morten Rix Hansen, Asbjørn Hróbjartsson, Lars Videbæk, Zandra Nymand Ennis, Manan Pareek, Niels Herluf Paulsen, Martin Broe, Morten Olesen, Anton Pottegård, Per Damkier, Jesper Hallas. Postponement of Death by Pharmacological Heart Failure Treatment: A Meta-Analysis of Randomized Clinical Trials. The American Journal of Medicine 2020; 133(6): e280 doi: 10.1016/j.amjmed.2019.11.015
|
| 10 |
Peysh A. Patel, Noman Ali, Ashwin Roy, Stuart Pinder, Richard M. Cubbon, Mark T. Kearney, Klaus K. Witte. Effects of Ivabradine on Hemodynamic and Functional Parameters in Left Ventricular Systolic Dysfunction: a Systematic Review and Meta-analysis. Journal of General Internal Medicine 2018; 33(9): 1561 doi: 10.1007/s11606-018-4578-4
|
| 11 |
Carina Benstoem, Christina Kalvelage, Thomas Breuer, Nicole Heussen, Gernot Marx, Christian Stoppe, Vincent Brandenburg. Ivabradine as adjuvant treatment for chronic heart failure. Cochrane Database of Systematic Reviews 2020; 2020(11) doi: 10.1002/14651858.CD013004.pub2
|